| Literature DB >> 10677042 |
S G Khasar1, Y H Lin, A Martin, J Dadgar, T McMahon, D Wang, B Hundle, K O Aley, W Isenberg, G McCarter, P G Green, C W Hodge, J D Levine, R O Messing.
Abstract
There is great interest in discovering new targets for pain therapy since current methods of analgesia are often only partially successful. Although protein kinase C (PKC) enhances nociceptor function, it is not known which PKC isozymes contribute. Here, we show that epinephrine-induced mechanical and thermal hyperalgesia and acetic acid-associated hyperalgesia are markedly attenuated in PKCepsilon mutant mice, but baseline nociceptive thresholds are normal. Moreover, epinephrine-, carrageenan-, and nerve growth factor- (NGF-) induced hyperalgesia in normal rats, and epinephrine-induced enhancement of tetrodotoxin-resistant Na+ current (TTX-R I(Na)) in cultured rat dorsal root ganglion (DRG) neurons, are inhibited by a PKCepsilon-selective inhibitor peptide. Our findings indicate that PKCepsilon regulates nociceptor function and suggest that PKCepsilon inhibitors could prove useful in the treatment of pain.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10677042 DOI: 10.1016/s0896-6273(00)80837-5
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173